Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
WIRB-Copernicus Group (WCG)
WIRB-Copernicus Group (WCG)
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Regulatory
WCG Clinical Services Division opens office in Japan
Its expanded presence in the Asia-Pacific region will strengthen its ability to support increasingly complex, global clinical trials
Finance
WIRB-Copernicus Group clinical services division acquires ACI Clinical
WCG Clinical Services Division expands portfolio to include specialist in endpoint adjudication and data monitoring safety committees
Regulatory
WCG expands portfolio to include drug safety solution provider
WIRB Copernicus Group (WCG) announced its acquisition of Vigilare International
Media
WCG’S MedAvante-ProPhase hires business leaders to grow and improve clinical trial data
Regulatory
New tool to better inform patients about clinical trials
WIRB-Copernicus Group, provider of solutions to measurably improve the quality and efficiency of clinical research has acquired Patient Genesis’ ConsentNow eConsent technology
Regulatory
WIRB-Copernicus Group celebrates IBC review milestone
WIRB-Copernicus IRB Group announced its IBC Services has achieved a major milestone in administering 4000 convened IBC meetings globally
Regulatory
WIRB-Copernicus Group acquires MedAvante and ProPhase
Names Jeffrey Litwin as the Chief Executive Officer (CEO) of the combined company
Subscribe now